$ Value
$0
Shares
2,816
Price
$0
Filed
Apr 2
Insider
Name
Xanthopoulos Kleanthis Gabriel
Title
—
CIK
0002115875
Roles
Transaction Details
Transaction Date
2026-03-31
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
82,816
Footnotes
In accordance with the Connect Biopharma Holdings Limited Non-Employee Director Compensation Program, Dr. Xanthopoulos elected to receive fully vested shares in lieu of a portion of cash compensation for his 2026 annual board retainers. Accordingly, the fully vested ordinary shares were granted to Dr. Xanthopoulos for his service as a director during the first quarter of 2026. The number of shares received in lieu of cash was calculated by dividing the applicable value of the equity by the average closing price of our ordinary shares over the 30 consecutive trading days immediately preceding March 31, 2026, rounded down to the nearest whole share.
Filing Info
Xanthopoulos Kleanthis Gabriel's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | CNTB | A | $0 |
Other Insiders at CNTB (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Huang James | $4.0M | — | 2026-03-31 |
| LIU JEAN I | — | — | 2026-03-31 |